Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000886163-17-000048
Filing Date
2017-04-14
Accepted
2017-04-14 09:22:32
Documents
5
Effectiveness Date
2017-04-14

Document Format Files

Seq Description Document Type Size
1 DEFA14A proxynotice.htm DEFA14A 18748
2 a02ke5cligandpharmaceuti001.jpg GRAPHIC 235727
3 a02ke5cligandpharmaceuti002.jpg GRAPHIC 105130
4 a02ke7bligandpharmaceuti001.jpg GRAPHIC 206341
5 a02ke7bligandpharmaceuti002.jpg GRAPHIC 172051
  Complete submission text file 0000886163-17-000048.txt   997780
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 17762235
SIC: 2834 Pharmaceutical Preparations